Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use Disorder

NCT02669901 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT02669901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02669901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use Disorder
Lead sponsor
University of New Mexico
Phase
Not applicable
Overall status
Completed
Start date
April 4, 2016
Completion date
August 20, 2020
Enrollment
395 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opiate antagonist overdose, opioid-related disorders